Selected research
Market Analysis & Forecast
Global Human Prothrombin Complex Concentrate Market Analysis and Forecast 2026-2032
Market perspective
The global Human Prothrombin Complex Concentrate market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human Prothrombin Complex Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Human Prothrombin Complex Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Human Prothrombin Complex Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Human Prothrombin Complex Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Human Prothrombin Complex Concentrate include Takeda, Weiguang Biology, Thailand Bio, Shanghai Emerging Pharmaceuticals, Shanghai RAAS, Green Cross (China) Biological Products Co., Ltd., Jiangxi Boya Biopharmaceutical Co., Ltd., Hualan Bio and Guangdong Shuanglin Biopharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Human Prothrombin Complex Concentrate, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Human Prothrombin Complex Concentrate, also provides the sales of main regions and countries. Of the upcoming market potential for Human Prothrombin Complex Concentrate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Prothrombin Complex Concentrate sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Prothrombin Complex Concentrate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Prothrombin Complex Concentrate sales, projected growth trends, production technology, application and end-user industry.
Human Prothrombin Complex Concentrate Segment by Company
Takeda
Weiguang Biology
Thailand Bio
Shanghai Emerging Pharmaceuticals
Shanghai RAAS
Green Cross (China) Biological Products Co., Ltd.
Jiangxi Boya Biopharmaceutical Co., Ltd.
Hualan Bio
Guangdong Shuanglin Biopharmaceutical Co., Ltd.
Beijing Tiantan Biological Products Co., Ltd.
Beijing Bohui Innovative Biotechnology Group Co., Ltd.
Octapharma
Grifols
CSL
Biotest
Human Prothrombin Complex Concentrate Segment by Type
500 IU
1000 IU
Human Prothrombin Complex Concentrate Segment by Application
Hemophilia B
Vitamin K Deficiency
Other
Human Prothrombin Complex Concentrate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex Concentrate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Human Prothrombin Complex Concentrate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Human Prothrombin Complex Concentrate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Prothrombin Complex Concentrate sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 500 IU
- 1000 IU
Applications
- Hemophilia B
- Vitamin K Deficiency
- Other
Companies covered
- Takeda
- Weiguang Biology
- Thailand Bio
- Shanghai Emerging Pharmaceuticals
- Shanghai RAAS
- Green Cross (China) Biological Products Co., Ltd.
- Jiangxi Boya Biopharmaceutical Co., Ltd.
- Hualan Bio
- Guangdong Shuanglin Biopharmaceutical Co., Ltd.
- Beijing Tiantan Biological Products Co., Ltd.
- Beijing Bohui Innovative Biotechnology Group Co., Ltd.
- Octapharma
- Grifols
- CSL
- Biotest
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Human Prothrombin Complex Concentrate Market by Type
- 1.2.1 Global Human Prothrombin Complex Concentrate Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 500 IU
- 1.2.3 1000 IU
- 1.3 Human Prothrombin Complex Concentrate Market by Application
- 1.3.1 Global Human Prothrombin Complex Concentrate Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hemophilia B
- 1.3.3 Vitamin K Deficiency
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Human Prothrombin Complex Concentrate Market Dynamics
- 2.1 Human Prothrombin Complex Concentrate Industry Trends
- 2.2 Human Prothrombin Complex Concentrate Industry Drivers
- 2.3 Human Prothrombin Complex Concentrate Industry Opportunities and Challenges
- 2.4 Human Prothrombin Complex Concentrate Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Human Prothrombin Complex Concentrate Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Human Prothrombin Complex Concentrate Revenue by Region
- 3.2.1 Global Human Prothrombin Complex Concentrate Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Human Prothrombin Complex Concentrate Revenue by Region (2021-2026)
- 3.2.3 Global Human Prothrombin Complex Concentrate Revenue by Region (2027-2032)
- 3.2.4 Global Human Prothrombin Complex Concentrate Revenue Market Share by Region (2021-2032)
- 3.3 Global Human Prothrombin Complex Concentrate Sales Estimates and Forecasts 2021-2032
- 3.4 Global Human Prothrombin Complex Concentrate Sales by Region
- 3.4.1 Global Human Prothrombin Complex Concentrate Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Human Prothrombin Complex Concentrate Sales by Region (2021-2026)
- 3.4.3 Global Human Prothrombin Complex Concentrate Sales by Region (2027-2032)
- 3.4.4 Global Human Prothrombin Complex Concentrate Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Human Prothrombin Complex Concentrate Revenue by Manufacturers
- 4.1.1 Global Human Prothrombin Complex Concentrate Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Human Prothrombin Complex Concentrate Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Human Prothrombin Complex Concentrate Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Human Prothrombin Complex Concentrate Sales by Manufacturers
- 4.2.1 Global Human Prothrombin Complex Concentrate Sales by Manufacturers (2021-2026)
- 4.2.2 Global Human Prothrombin Complex Concentrate Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Human Prothrombin Complex Concentrate Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Human Prothrombin Complex Concentrate Sales Price by Manufacturers (2021-2026)
- 4.4 Global Human Prothrombin Complex Concentrate Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Human Prothrombin Complex Concentrate Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Human Prothrombin Complex Concentrate Manufacturers, Product Type & Application
- 4.7 Global Human Prothrombin Complex Concentrate Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Human Prothrombin Complex Concentrate Market CR5 and HHI
- 4.8.2 2025 Human Prothrombin Complex Concentrate Tier 1, Tier 2, and Tier 3
5 Human Prothrombin Complex Concentrate Market by Type
- 5.1 Global Human Prothrombin Complex Concentrate Revenue by Type
- 5.1.1 Global Human Prothrombin Complex Concentrate Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Human Prothrombin Complex Concentrate Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2021-2032)
- 5.2 Global Human Prothrombin Complex Concentrate Sales by Type
- 5.2.1 Global Human Prothrombin Complex Concentrate Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Human Prothrombin Complex Concentrate Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2032)
- 5.3 Global Human Prothrombin Complex Concentrate Price by Type
6 Human Prothrombin Complex Concentrate Market by Application
- 6.1 Global Human Prothrombin Complex Concentrate Revenue by Application
- 6.1.1 Global Human Prothrombin Complex Concentrate Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Human Prothrombin Complex Concentrate Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Human Prothrombin Complex Concentrate Revenue Market Share by Application (2021-2032)
- 6.2 Global Human Prothrombin Complex Concentrate Sales by Application
- 6.2.1 Global Human Prothrombin Complex Concentrate Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Human Prothrombin Complex Concentrate Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2032)
- 6.3 Global Human Prothrombin Complex Concentrate Price by Application
7 Company Profiles
- 7.1 Takeda
- 7.1.1 Takeda Company Information
- 7.1.2 Takeda Business Overview
- 7.1.3 Takeda Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Takeda Human Prothrombin Complex Concentrate Product Portfolio
- 7.1.5 Takeda Recent Developments
- 7.2 Weiguang Biology
- 7.2.1 Weiguang Biology Company Information
- 7.2.2 Weiguang Biology Business Overview
- 7.2.3 Weiguang Biology Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Weiguang Biology Human Prothrombin Complex Concentrate Product Portfolio
- 7.2.5 Weiguang Biology Recent Developments
- 7.3 Thailand Bio
- 7.3.1 Thailand Bio Company Information
- 7.3.2 Thailand Bio Business Overview
- 7.3.3 Thailand Bio Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Thailand Bio Human Prothrombin Complex Concentrate Product Portfolio
- 7.3.5 Thailand Bio Recent Developments
- 7.4 Shanghai Emerging Pharmaceuticals
- 7.4.1 Shanghai Emerging Pharmaceuticals Company Information
- 7.4.2 Shanghai Emerging Pharmaceuticals Business Overview
- 7.4.3 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product Portfolio
- 7.4.5 Shanghai Emerging Pharmaceuticals Recent Developments
- 7.5 Shanghai RAAS
- 7.5.1 Shanghai RAAS Company Information
- 7.5.2 Shanghai RAAS Business Overview
- 7.5.3 Shanghai RAAS Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Shanghai RAAS Human Prothrombin Complex Concentrate Product Portfolio
- 7.5.5 Shanghai RAAS Recent Developments
- 7.6 Green Cross (China) Biological Products Co., Ltd.
- 7.6.1 Green Cross (China) Biological Products Co., Ltd. Company Information
- 7.6.2 Green Cross (China) Biological Products Co., Ltd. Business Overview
- 7.6.3 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
- 7.6.5 Green Cross (China) Biological Products Co., Ltd. Recent Developments
- 7.7 Jiangxi Boya Biopharmaceutical Co., Ltd.
- 7.7.1 Jiangxi Boya Biopharmaceutical Co., Ltd. Company Information
- 7.7.2 Jiangxi Boya Biopharmaceutical Co., Ltd. Business Overview
- 7.7.3 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
- 7.7.5 Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Developments
- 7.8 Hualan Bio
- 7.8.1 Hualan Bio Company Information
- 7.8.2 Hualan Bio Business Overview
- 7.8.3 Hualan Bio Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Hualan Bio Human Prothrombin Complex Concentrate Product Portfolio
- 7.8.5 Hualan Bio Recent Developments
- 7.9 Guangdong Shuanglin Biopharmaceutical Co., Ltd.
- 7.9.1 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Company Information
- 7.9.2 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Business Overview
- 7.9.3 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
- 7.9.5 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Developments
- 7.10 Beijing Tiantan Biological Products Co., Ltd.
- 7.10.1 Beijing Tiantan Biological Products Co., Ltd. Company Information
- 7.10.2 Beijing Tiantan Biological Products Co., Ltd. Business Overview
- 7.10.3 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
- 7.10.5 Beijing Tiantan Biological Products Co., Ltd. Recent Developments
- 7.11 Beijing Bohui Innovative Biotechnology Group Co., Ltd.
- 7.11.1 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Company Information
- 7.11.2 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Business Overview
- 7.11.3 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
- 7.11.5 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Developments
- 7.12 Octapharma
- 7.12.1 Octapharma Company Information
- 7.12.2 Octapharma Business Overview
- 7.12.3 Octapharma Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Octapharma Human Prothrombin Complex Concentrate Product Portfolio
- 7.12.5 Octapharma Recent Developments
- 7.13 Grifols
- 7.13.1 Grifols Company Information
- 7.13.2 Grifols Business Overview
- 7.13.3 Grifols Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Grifols Human Prothrombin Complex Concentrate Product Portfolio
- 7.13.5 Grifols Recent Developments
- 7.14 CSL
- 7.14.1 CSL Company Information
- 7.14.2 CSL Business Overview
- 7.14.3 CSL Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 CSL Human Prothrombin Complex Concentrate Product Portfolio
- 7.14.5 CSL Recent Developments
- 7.15 Biotest
- 7.15.1 Biotest Company Information
- 7.15.2 Biotest Business Overview
- 7.15.3 Biotest Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Biotest Human Prothrombin Complex Concentrate Product Portfolio
- 7.15.5 Biotest Recent Developments
8 North America
- 8.1 North America Human Prothrombin Complex Concentrate Market Size by Type
- 8.1.1 North America Human Prothrombin Complex Concentrate Revenue by Type (2021-2032)
- 8.1.2 North America Human Prothrombin Complex Concentrate Sales by Type (2021-2032)
- 8.1.3 North America Human Prothrombin Complex Concentrate Price by Type (2021-2032)
- 8.2 North America Human Prothrombin Complex Concentrate Market Size by Application
- 8.2.1 North America Human Prothrombin Complex Concentrate Revenue by Application (2021-2032)
- 8.2.2 North America Human Prothrombin Complex Concentrate Sales by Application (2021-2032)
- 8.2.3 North America Human Prothrombin Complex Concentrate Price by Application (2021-2032)
- 8.3 North America Human Prothrombin Complex Concentrate Market Size by Country
- 8.3.1 North America Human Prothrombin Complex Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Human Prothrombin Complex Concentrate Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Human Prothrombin Complex Concentrate Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Human Prothrombin Complex Concentrate Market Size by Type
- 9.1.1 Europe Human Prothrombin Complex Concentrate Revenue by Type (2021-2032)
- 9.1.2 Europe Human Prothrombin Complex Concentrate Sales by Type (2021-2032)
- 9.1.3 Europe Human Prothrombin Complex Concentrate Price by Type (2021-2032)
- 9.2 Europe Human Prothrombin Complex Concentrate Market Size by Application
- 9.2.1 Europe Human Prothrombin Complex Concentrate Revenue by Application (2021-2032)
- 9.2.2 Europe Human Prothrombin Complex Concentrate Sales by Application (2021-2032)
- 9.2.3 Europe Human Prothrombin Complex Concentrate Price by Application (2021-2032)
- 9.3 Europe Human Prothrombin Complex Concentrate Market Size by Country
- 9.3.1 Europe Human Prothrombin Complex Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Human Prothrombin Complex Concentrate Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Human Prothrombin Complex Concentrate Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Human Prothrombin Complex Concentrate Market Size by Type
- 10.1.1 China Human Prothrombin Complex Concentrate Revenue by Type (2021-2032)
- 10.1.2 China Human Prothrombin Complex Concentrate Sales by Type (2021-2032)
- 10.1.3 China Human Prothrombin Complex Concentrate Price by Type (2021-2032)
- 10.2 China Human Prothrombin Complex Concentrate Market Size by Application
- 10.2.1 China Human Prothrombin Complex Concentrate Revenue by Application (2021-2032)
- 10.2.2 China Human Prothrombin Complex Concentrate Sales by Application (2021-2032)
- 10.2.3 China Human Prothrombin Complex Concentrate Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Human Prothrombin Complex Concentrate Market Size by Type
- 11.1.1 Asia Human Prothrombin Complex Concentrate Revenue by Type (2021-2032)
- 11.1.2 Asia Human Prothrombin Complex Concentrate Sales by Type (2021-2032)
- 11.1.3 Asia Human Prothrombin Complex Concentrate Price by Type (2021-2032)
- 11.2 Asia Human Prothrombin Complex Concentrate Market Size by Application
- 11.2.1 Asia Human Prothrombin Complex Concentrate Revenue by Application (2021-2032)
- 11.2.2 Asia Human Prothrombin Complex Concentrate Sales by Application (2021-2032)
- 11.2.3 Asia Human Prothrombin Complex Concentrate Price by Application (2021-2032)
- 11.3 Asia Human Prothrombin Complex Concentrate Market Size by Country
- 11.3.1 Asia Human Prothrombin Complex Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Human Prothrombin Complex Concentrate Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Human Prothrombin Complex Concentrate Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Human Prothrombin Complex Concentrate Market Size by Type
- 12.1.1 SAMEA Human Prothrombin Complex Concentrate Revenue by Type (2021-2032)
- 12.1.2 SAMEA Human Prothrombin Complex Concentrate Sales by Type (2021-2032)
- 12.1.3 SAMEA Human Prothrombin Complex Concentrate Price by Type (2021-2032)
- 12.2 SAMEA Human Prothrombin Complex Concentrate Market Size by Application
- 12.2.1 SAMEA Human Prothrombin Complex Concentrate Revenue by Application (2021-2032)
- 12.2.2 SAMEA Human Prothrombin Complex Concentrate Sales by Application (2021-2032)
- 12.2.3 SAMEA Human Prothrombin Complex Concentrate Price by Application (2021-2032)
- 12.3 SAMEA Human Prothrombin Complex Concentrate Market Size by Country
- 12.3.1 SAMEA Human Prothrombin Complex Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Human Prothrombin Complex Concentrate Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Human Prothrombin Complex Concentrate Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Human Prothrombin Complex Concentrate Value Chain Analysis
- 13.1.1 Human Prothrombin Complex Concentrate Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Human Prothrombin Complex Concentrate Production Mode & Process
- 13.2 Human Prothrombin Complex Concentrate Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Human Prothrombin Complex Concentrate Distributors
- 13.2.3 Human Prothrombin Complex Concentrate Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst